Share on LinkedInShare on LinkedIn

ARTICLE · 06 JULY 2012

Boosting capital raisings for mid/small caps on the ASX

The ASX has released draft proposals to enhance the capital raising environment for mid/small cap companies.

AustraliaFinance and Banking

Recently1, the ASX released draft proposals to enhance the capital raising environment for mid/small cap companies (MSC) currently listed on ASX2. A significant proposal is to enable MSCs to seek a 12-month mandate from shareholders to issue up to an additional 10% of the issued capital of the company without further approval. Given the size of most ASX-listed life sciences companies, this proposal is very significant for the sector.

This article briefly looks at:

  • What exactly is the proposal?
  • What are the benefits of the proposal?
  • Is there devil in the detail of the proposal?
  • Will the changes alter the capital raising process for MSCs in the life sciences sector?

What exactly is the proposal?

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from